Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2033 ARTÍCULOS , VIENDO DEL 1306 AL 1320

Morphological Features of Human Dendritic Spines

Renner J, Rasia-Filho AA.

Adv Neurobiol. 2023;34:367-496. doi: 10.1007/978-3-031-36159-3_9.

Functional connectivity changes in mild cognitive impairment: A meta-analysis of M/EEG studies

Buzi G, Fornari C, Perinelli A, Mazza V.

Clin Neurophysiol. 2023 Dec;156:183-195. doi: 10.1016/j.clinph.2023.10.011. Epub 2023 Nov 2.

Unlocking the therapeutic potential of natural stilbene: Exploring pterostilbene as a powerful ally against aging and cognitive decline

Dutta BJ, Rakshe PS, Maurya N, Chib S, Singh S.

Ageing Res Rev. 2023 Dec;92:102125. doi: 10.1016/j.arr.2023.102125. Epub 2023 Nov 17.

Cerebrovascular Hemodynamics in Cognitive Impairment and Dementia: A Systematic Review and Meta-Analysis of Transcranial Doppler Studies

Fresnais D, Ihle-Hansen H, Lundström E, Andersson ÅG, Fure B.

Dement Geriatr Cogn Disord. 2023;52(5-6):277-295. doi: 10.1159/000535422. Epub 2023 Nov 26.

Interplay Between Astroglial Endocannabinoid System and the Cognitive Dysfunction in Alzheimer's Disease

Rapaka D, Adiukwu PC, Challa SR, Bitra VR.

Physiol Res. 2023 Nov 28;72(5):575-586. doi: 10.33549/physiolres.935156.

How healthy participants value additional diagnostic testing with amyloid-PET in patients diagnosed with mild cognitive impairment - a bidding game experiment

van Maurik IS, Bakker ED, van Unnik AAJM, Broulikova HM, Zwan MD, van de Giessen E, Berkhof J, Bouwman FH, Bosmans JE, van der Flier WM.

Alzheimers Res Ther. 2023 Nov 28;15(1):208. doi: 10.1186/s13195-023-01346-y.

[Expert consensus on the application of amyloid-PET imaging in the diagnosis of Alzheimer's disease]

Chinese Society of Dementia and Cognitive lmpairment; Chinese Society of Nuclear Medicine.

Zhonghua Yi Xue Za Zhi. 2023 Dec 5;103(45):3615-3626. doi: 10.3760/cma.j.cn112137-20230909-00433.

Efficacy of the visual cognitive assessment test for mild cognitive impairment/mild dementia diagnosis: a meta-analysis

Hsu JH, Liu CC, Chen IW, Wu JY, Huang PY, Liu TH, Hung KC.

Front Public Health. 2023 Oct 31;11:1293710. doi: 10.3389/fpubh.2023.1293710. eCollection 2023.

Reducing fear and avoidance of memory loss improves mood and social engagement in community-based older adults: a randomized trial

Farina FR, Regan J, Marquez M, An H, O'Loughlin P, Pavithra P, Taddeo M, Knight RC, Bennett M, Lenaert B, Griffith JW.

BMC Geriatr. 2023 Nov 29;23(1):786. doi: 10.1186/s12877-023-04470-4.

The association between bullous pemphigoid and cognitive outcomes in middle-aged and older adults: A systematic review and meta-analysis

Zhou Q, Xiong Z, Yang D, Xiong C, Li X.

PLoS One. 2023 Nov 30;18(11):e0295135. doi: 10.1371/journal.pone.0295135. eCollection 2023.

A Stable and Scalable Digital Composite Neurocognitive Test for Early Dementia Screening Based on Machine Learning: Model Development and Validation Study

Gu D, Lv X, Shi C, Zhang T, Liu S, Fan Z, Tu L, Zhang M, Zhang N, Chen L, Wang Z, Wang J, Zhang Y, Li H, Wang L, Zhu J, Zheng Y, Wang H, Yu X; Alzheimer's Disease Neuroimaging Initiative (ADNI).

J Med Internet Res. 2023 Dec 1;25:e49147. doi: 10.2196/49147.

Efficacy and Safety of Cilostazol in Mild Cognitive Impairment: A Randomized Clinical Trial

Saito S, Suzuki K, Ohtani R, Maki T, Kowa H, Tachibana H, Washida K, Kawabata N, Mizuno T, Kanki R, Sudoh S, Kitaguchi H, Shindo K, Shindo A, Oka N, Yamamoto K, Yasuno F, Kakuta C, Kakuta R, Yamamoto Y, Hattori Y, Takahashi Y, Nakaoku Y, Tonomura S, Oishi N, Aso T, Taguchi A, Kagimura T, Kojima S, Taketsuna M, Tomimoto H, Takahashi R, Fukuyama H, Nagatsuka K, Yamamoto H, Fukushima M, Ihara M; COMCID Trial Investigator Group.

JAMA Netw Open. 2023 Dec 1;6(12):e2344938. doi: 10.1001/jamanetworkopen.2023.44938.

Increased risk of osteoporosis in patients with cognitive impairment: a systematic review and meta-analysis

Xie C, Wang C, Luo H.

BMC Geriatr. 2023 Dec 4;23(1):797. doi: 10.1186/s12877-023-04548-z.

Anticholinergic deprescribing interventions for reducing risk of cognitive decline or dementia in older adults with and without prior cognitive impairment

Taylor-Rowan M, Alharthi AA, Noel-Storr AH, Myint PK, Stewart C, McCleery J, Quinn TJ.

Cochrane Database Syst Rev. 2023 Dec 8;12(12):CD015405. doi: 10.1002/14651858.CD015405.pub2.

NeuroEPO plus (NeuralCIM(®)) in mild-to-moderate Alzheimer's clinical syndrome: the ATHENEA randomized clinical trial

Sosa S, Bringas G, Urrutia N, Peñalver AI, López D, González E, Fernández A, Hernández ZM, Viña A, Peña Y, Batista JF, Valenzuela C, León K, Crombet T, Rodríguez T, Pérez L; ATHENEA Investigators.

Alzheimers Res Ther. 2023 Dec 13;15(1):215. doi: 10.1186/s13195-023-01356-w.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias